In this study, PSMA3-AS1 was testified to be up-regulated in glioma cells, and then loss-of-function assays were carried out to verify the effects of PSMA3-AS1 on glioma cell proliferation and apoptosis. Here, PSMA3 is linked to central nervous system cancer.